<SEC-DOCUMENT>0001193125-13-257042.txt : 20130613
<SEC-HEADER>0001193125-13-257042.hdr.sgml : 20130613
<ACCEPTANCE-DATETIME>20130613095042
ACCESSION NUMBER:		0001193125-13-257042
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130613
FILED AS OF DATE:		20130613
DATE AS OF CHANGE:		20130613

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prima BioMed Ltd
		CENTRAL INDEX KEY:			0001506184
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35428
		FILM NUMBER:		13910268

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 7, 151 MACQUARIE STREET
		CITY:			SYDNEY, NEW SOUTH WALES
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		612 9276 1224

	MAIL ADDRESS:	
		STREET 1:		LEVEL 7, 151 MACQUARIE STREET
		CITY:			SYDNEY, NEW SOUTH WALES
		STATE:			C3
		ZIP:			2000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d553744d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 6-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dated June 13, 2013 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Commission File Number 001-35428 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>P<SMALL>RIMA</SMALL> B<SMALL>IO</SMALL>M<SMALL>ED</SMALL> L<SMALL>TD</SMALL> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name as Specified in its Charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Translation of Registrant&#146;s Name) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Level 7, 151 Macquarie Street </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sydney, 2000 New South Wales, Australia
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive office) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form
20-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1):&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b) (7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check
mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If &#147;Yes&#148; is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): Not applicable. </FONT></P> <P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: June 13, 2013 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prima BioMed Ltd</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Matthew Lehman</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Matthew Lehman</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:25pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:75pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Exhibit</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prima BioMed Ltd &#150; Completion of Entitlement Offer</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d553744dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g553744ex991pg1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ASX Announcement </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Release Code: PRR </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">13&nbsp;June 2013 </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prima BioMed Ltd &#150; Completion of Entitlement Offer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Prima BioMed Ltd ABN 90 009 237 889 (<B>Company</B>) is pleased to announce the successful completion of its 1 for 4 non-renounceable entitlement offer (<B>Entitlement Offer</B>) of options
(<B>Options</B>) to acquire fully paid ordinary shares in the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Entitlement Offer, raised a total of $1,547,574. As a consequence,
77,378,699 Options will be issued on Tuesday, 18&nbsp;June 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross proceeds from the Entitlement Offer, along with the funds raised from
the Company&#146;s recently completed share purchase plan (<B>SPP</B>) will be used to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">co-fund up to three phase 2 trials of CVac&#153; in additional cancer indications and continue the ongoing clinical program;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">continue CVac manufacturing optimisation programs to move toward a commercially successful and global product manufacturing platform;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provide general working capital form the Company and add security to the balance sheet, </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">and to pay the costs of the Entitlement Offer and SPP. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">It is expected that the Options will commence trading on ASX under the code PRRO on a normal (T+3) settlement basis on Wednesday, 19&nbsp;June 2013. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Further information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you would like
further information regarding the Entitlement Offer, please see the prospectus lodged with the Australian Securities and Investments Commission and given to ASX in each case on 13&nbsp;May 2013 or visit the Company&#146;s website
(<U>www.primabiomed.com</U>). </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About Prima BioMed </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Prima BioMed is a globally active leader in the development of personalised bio-therapeutic products for cancer. Prima BioMed is dedicated to leveraging its technology and expertise to bring innovative
treatment options to market for patients and to maximise value to shareholders. Prima BioMed&#146;s lead product is CVac&#153;, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients in remission and soon
to be in trials for other cancer types. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disclaimer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>The information contained in this announcement does not constitute an offer to sell securities or the solicitation of an offer to buy, or recommendation for investment in, any securities or financial
products within the United States or any other jurisdiction and does not and will not form any part of any contract for the acquisition of securities in the Company. In the United States, securities may not be sold absent registration or an
exemption from registration under the Securities Act. The information in this announcement is not intended as financial advice. Moreover, none of the information in this announcement is intended to constitute a prospectus within the meaning of the
applicable laws of any jurisdiction and this announcement is not directed to any person in any country in which the distribution of such information is unlawful. Moreover, you should be aware of the fact that investments in undertakings, securities
or other financial instruments involve risks. Past results do not guarantee future performance. This announcement contains certain &#147;forward-looking&#148; statements. The words &#147;intends&#148;, &#147;expected&#148;, &#147;proposed&#148;,
&#147;forecast&#148;, &#147;target&#148;, and &#147;will&#148; and other similar expressions are intended to identify forward looking statements. Forward-looking statements, opinions and estimates provided in this announcement are based on
assumptions and contingencies which are subject to change without notice. Forward-looking statements are provided as a general guide only and should not be relied upon as an indication or guarantee of future performance. There can be no assurance
that actual outcomes will not differ materially from these statements. This dates referred to in this announcement are indicative only and subject to change. The Company reserves the right, subject to the ASX Listing Rules and the Corporations Act
2001 (Cth), to alter the dates at its discretion, without prior notice. </I></FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g553744ex991pg1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g553744ex991pg1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`=P+&`P$1``(1`0,1`?_$`-\``0`!`P4!`0``````
M```````'!`4&`0(#"`D*"P$!``(#`0$!`0$```````````$"`P0%!@<("@D0
M```%`P($`@<%!08#!@,)``$"`P0%``8'$0@A,1()05%A<8&1(A,4L<$R%0JA
MT4)2<O!BDB,6%_&").$S)28G&&,TU**RPD-3<S5&*!$``@$#`04$!@0'"@D)
M"0````$"$0,$!2$Q$@8'05%A<8&1(C(3"*&QP=%28G*2LA05\.%"@L(C,V,D
M"=)#4],T1&1T%J)SH^.4)55U%X.3L\-4-44V5O_:``P#`0`"$0,1`#\`^_B@
M%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4
M`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0&%Y%R-8F(K&NG)N3[M@+#Q]
M9$,\N&[KPNB3:P\!;T+'IBJ[D9.1>*)(((IE```-1.H<Q2$`QC``@===HVZ)
M?>%9CK.%E6+.6EM\N)0P85NB^$7,/>V8+?1653/E!I9JR)'-HXZG3IB$"#\W
MYG*-2_6*(-45$2JO+>";;\R_B_&?TY\BY*LFP4W``9'_`%==<);QW!!U#J;I
MR;Q!5<`,'$2E$/36AF:MI>FP_P"\LFQ:GV)R2?J;K0[N@\G\W\U3E;Y;TS4\
M^$/>>-BW;Z7G.W&7#YLNUF9#LC(S`\IC^][5O6+`1#\TM2>BKA9)'TX$67BG
M;@B9P_E,)1&LN)GX.I6ED:?>MW+*V/A==IKZSR_S%RWF?J',F#E8&8U56[]F
M[:DUWTN1B=2K*WT62UW/OME>>&)<.[BW\4YN[$363==>/MR&/$%3I*W3ABZ'
M14"2%PP2B9D9VV771+Q2Y.L@.VIB.C;1RCOA0"@%`*`4`H!0"@%`*`4`H!0"
M@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`
M4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0
M"@%`*`4!H8W2`CH(Z>`<Z`^(ONI;BKA[IW>:VZ=FRT9^09;6,892@97<VPAG
MJS=/)]TV=`JY*OV)FCH'3^IA;'M.."):MS]299EXX6,`G21$DF2.R-3ZS=S>
M0#[:MK&5K]Q_;[%!3$N)Y1:RK?:,TT8:+_)(M"-MQLFP1*1!.(@P^4(HE`"`
MW1Z`T"N+S'J-S1]`R]4LKBO0MOA7:WM6[PK7T'T#H_R?I_/_`%1T+DC4[BMZ
M;J.J8]B[)R4?YKB<KGM-JE56'%78VNT^!2_+\O3*EU2U]9(N>7O:[Y]VL^E+
M@GWBK]XX77.*AB(BL8R;1HD(]*2"0$22(`%*4``*_#>=G9^H9CS=1E)W[NZK
M;KY5^I']-W*O*_+?(FBXVB\GX,--T3%L?"MVK:59)?PIM;77ME)NKWLSO;_G
M[)NV3)-OY0Q1<+^!F(:0;+2,:U76)#W3$@ND+^W[BC$S@UDXZ2;E%,P*$,9,
M1`Y!*<H&K?T'7\W0-5LZA@R;NPN).-6U)/?'AKMKW4/*]5NF/)O5WDK4.6.;
M\:SD6KV/.5NX^%7,>]&+<+\)^\G#;LK1UHTSZ-_U!NW0FXWMBR6Y6T0D[+S[
MM"1M?=AA^\X1=:+O&SCQ9(I_?</%S38R#IF*EM.#N1Z1#5[&-SCQ+Q_=.-<E
M>QK=^::G<@IM/L<DG2G93=0_F%S\/]G:KEZ;\3XRQ<J[94Z4XE;DTGXII;&=
MD>QGW&G?<FV)V;E*]5689QQS+N<29U29$3;HR-[6Y'L'3&]&[)+X6;2_;<>M
M9$4R@5-)X=PD0`(F`5F9IR5&7?O$=UAGVF<*XPS"^PJ[S:EDC*(XV+!,[W;6
M,>'$+4F[G&84D'5O7$1V0`AA1^2":?\`WG5U\-!@BC/&N*_5H,K.<V7,;E>V
M?N:PKB^^RL'=OY&2F`EFDM$/T"/$9BVV=U618$;=S55@H#A(&,B8RR`@<@&`
M0H0>H6_WOAX@VA[&]O\`ORP]8?\`[H<3;B+UAK6L[\GO`M@J-F4K;ES3:TA(
MK2=NSB[63AGML+Q[V/5;IK-W93E.8!3$H@>4Z_ZLJ[+-A;:OW+W:EW(6)B>Z
MDXUU#Y$/=SA*"EXZ63*O'R%NRUS8OMJV9Y.0:G!1J!)%,CDH@)#Z"`T%&>Y3
MCNT8-N_MAY&[GN!H66RECFP<>W+>"^/Y1TG9=V(W%9[]",N/']QJG;3K>`GX
MIZJ)5%"$=H'()%4C*)*$,(FC+]VENX^V[I.U5YN;9XE=893:Y5O7&/\`HYY=
MJ%Z*G/9[*W78S/YRV@X!,$Y#\_``1^0(I_*_$;JX"#KGAKO<XUS)W;<L=K**
MQ4^8/,;M+U8QN;#WHQ=1EUWOCR`@YV[+2;6>6#1<,3,`>2"(+_F"PF4C#_Y8
M`?X0HR0\R]W[&.'^ZMM][7CNPG<Q<>:K+3GIG*:=T-6<?8-T3<7=LO9-F/+7
M/$N',J\N=G:Y3`L#Q`$?KD?@/KQ$T9[""(!Q'@'F-"#YG.ZY^I"QYVT-T0[7
MH?;M)[@;EA;!MV[K\F(O)L=9#>TIFZ3/7L/:!F;FU+B,_DCVXBV?J'^8D"9'
MJ11+S&A-&>_FW;.=E[F,%8CW`8[<E=V5F+'MK9"MXX+$75;,[EBF\@>,=J)@
M4GYA#N53M'(``=#A$Y=`TH03/0'SN=V;OU*=L/<SC';3';3+CW#7!E#'$+?4
M&]MO(J5MR*TC.W?/6?'VG'6V2R;G?RTH[>PH"C\H_6J=8J94Q-H(B:,Z:6I^
MK!M&S<J6QC_>AV^]QFTF!N5TU2/>-S/'4DZ@H]PX(U6N%_9MQV/84Y*6]'K+
M%%TM'&=+HI@801.(`40HST][P'>2M_M68>P#F&/PNMN)@\^7'-0\&$'D!G9C
M5G&1MHM[NCYY"17MNY$I1I,LG1`2`I4]"F`_4/*A!WJRAOBP;@#9U%;U-P=P
MML78O<XTL?($B@X4/,RQ7]]P49+0MD6ZS:(I.[HNF1>R96;-!!(IG"@"<033
M*<Q`/FY=_JX+47+(W_;7;7W33VW.*F#QCW-1IB-:,4D2+G2,Y<)M[6DK-8/"
M@746BUP@8#?`90IN%`?2;L@WS[=^X1@B#W![;[L4G[0DG:\+.0TNU")O"Q;L
M8D14D[0O.!,JL>)G&1'"9P`IU6[A!0BR"BB1RG$#SZW>][C&>TWN7;9NW1)X
MN=W9(9W'';>[,JHWJRAX[%,AE.YI>V[.9R-LJP;Y>;%V>.1<*&!XUZ$79!`!
MYB)HR0.Z1W?<:]L.[MIMFWA8#K(4GN<R>:T'GT5UM+;_`-N;%82=N1$]D>13
M<Q$H>7:QSZYT"$:%^G^=T*?YI>FA%&3?W2=_S7MJ[0[FW6+XR7S`WMR[K#M8
M;,9W2A:*CP+WG484C\DXO#SR216'S@5Z/IS?-#@`EUUH#P*M#]4-N2R#;<3>
M=@]E_=)?%GS[<[N"NRSYN\;EMJ::IKJM5',3.PV#'L9(MR.4#IB=%4Y0.0Q1
M'4!"@/6+/O=SN#;OVI++[E=_[4[SM^X[E_T*G-[:+KN=>S[QL]Y>U\KV<1C-
M3<W9R3I!W'II$=B16*1.H10I="_BH-YY"1'ZL'(:MEL<MS7:4W(EPH[357_W
M5@;ODI.S5&B#I5FY=LKH<XC8VH[0;.6ZJ9S"_33*HF8ACE$!T`]QNVKWD]FO
M=$C)AE@NX)VU<JVI&)3%X83R2R:0E_1,0HHDW&X(@&+V2A;NMDCM8J1WL<Y6
M!`YR`N1$5$P,%&>KU`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@
M%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4
M!H(@`<1T#4./M#3WC0'Y@FWG/+'9O^ILOK(V;EC6]"'WR[C<?7E,3BHIHP$/
MFJ:O"U;>N:0=+"()1+0+IC'1UA$2D9&$_(*DRK;$_37N*VX*\K>F[7N*-:3M
MNW'#O86:BGI"+L)6)EFBK1\S<)ZZ';NVJQBCH/(=0&L-^S9R,>6)?AQV)Q:D
MO"2:?T-F;3=2U#1]2Q]6TJY*QJ>'>C=M75OC.,E.+7E))[=A\TV>.P!=![GD
M9;;?ENVF]HOG*KEE9F3D9=&2MY-8XF+',[HA&<F699M0'I3.X;(K`0``QE!U
M$?SYK'1"Y;RKM_ES*X,::I&W=]IP_)EN/]8^F?\`>6X-C2K&G]6=#R;VL6;?
M#+4,"5OXM]]]VQ>E&WM[5&5.U$G[3.Q*VL&^8#(.YC($#?J-LR+68C<:V0S?
MIVY)2;!8CEB>Z)V939O)&-0<)%.9FBU1(OITJ*"3J(;H\I=&UIN5#-UV_"\X
M.J@H_P`)/8V_#P/'];/[Q;5.;.7<WE+I=@9&FXV=:E9N9F3<B[RLR7MJW9MU
MA"<MB5SB;CMX5MJ=AN_SN0LW;3VIMU*]Q/VC6?R_8[W`6.(54Z1'5P79D],\
M"HV8H=0G4)"VT+^26$I>E-!F.NFH5]ZEP[%'<E0_S`L+8W2?$Y-MR=92?X3>
MWWCQ!_1BPURML4[[9M9-T2SGV2\-1$4JIU@R<W+$6C=;F=!J`_Y9W+:+E8_Y
MQB\>DZ8#X51F2>\F+]9*0RFR';"F73J4W0K$+KP#J-B:^2AJ/@&HU):'[OI/
M*;?1WP-J&ZSM&X8[:^#,2Y<RIN#_`-L]MN.I*2FK"9I1%D73B6.L]&7E;&*P
ME9VYKEN%\\MY>-8?2LD0.W>'$YP*(I'@QO>4G<AVN9;VC_IM-@6),X1+ZU\D
MOMV$KD&;LR6`2REC-\C0>7[GAK6ED!,;Z.6CH9^@=XWYMW2JB1@ZR&H([T8]
MN$[^UI93[3^.NV):^UB\(&\+FV_8;P/*9AS3/V];V.V3:T6%JQ+V_K4;KMU%
M'395S"%58R#EPT;1Q5"KJ'-\OI-)D:2?$SV?BMA-Y=N_],9O(PWD>ZK<NW(5
M\8CR=FV[W-F2I)ZS(=_D%.UB1MO6Q/(B#6?8QMO0K,57Z!0;.W2BJB(G2$AS
M"*IR,A_3"9.@,*=D?,^8KJ630MO%>:]S>1)U550$B!%V;8EE7"]+UF$H`91"
M/$I0YB80`.(U#(GO/DWV07EEO!V^;8'W4LINSQU@;I]\.5V\K<;E1=`PME[R
MB;9S$ZDW*P%1&.^AR\N*8B.@%8*]0?"&DEH[8T,SW&9NRSE'?[FGO50"RRV&
M,*]S+#^-[8F1,N91>&MI>5>V6RC7`?Y(QJ>,L8)BY*4=.N7)_..HG<J'ZA]]
M9?L3'F';MSM<LTW:8VLW'4QE27GA.F#<MG0MN+W2YD$SG,"9_F13<3)AKJ<P
ME`.(A4&);70_/\[96R*X^]:W[S6^#+T(#NZ\W6[>>/MOR\@W%P6W,MSKEMDN
M`_(E50Z&YK$@[8M>``Y.)&C]<@?B&I,K:5#UC_20[QGU^[8LP;&K_=KM\@[4
MKT=3]IP\FJI^9(8PO^4?#*0Y&RGQ))63DIK(H*ET#Y022!-`X492:[3Z\*@H
M?GY_J;+WDL9=Z'8%DF%M*7OZ9Q]CG"%[Q%BV^90L]>DG:NXJZIQC:D*9%J^5
M"6N%RQ*T;]*"QOFJET(8=`&498^Z=<>[3OXR5W<\M;4]LFYK`;?M48Q@+YF9
MXF6MU;7(*DJJ:Y6;.W98&\H&-X!NVC&D>("1L1,C-5\*)WKQLDF40$I46P]"
M/U;EGV[CO8=VU,?6C+?GUJ6)<TQ9ML3OU*+T)JW;7P="PD++@];*+-G@248R
M26^:F<Y%.OJ*(@.M08J,CO\`4871<-\X*['6TM&7>Q-F9;M?'T]<@-UC(MG<
MJI:N&\;P3QT`J%146@&%[R*J'6'P'7$VM"#[<;%V_8?QUA"W=N-L6#;33"ML
MV$VQHRQX>(8JVRYM!&+_`"AS%R<2=`6<B65;&.9X98ASNEE5%%1,<YA$#XZ?
MTZL>OM<[PG=BV*V@_>&P[;+V\I6W88S@ZS.-<8NR^6V;47T,`C]6WLV^!CU5
M!$#*%:I@81Z0T$T=*GSU]R>]\L;G]Y&^SNBV(X5>8OVZ;T,28FMJ:(=0R[?\
M@5N"(Q2M&*)ZI)L$TL.E<+B'):41TT$_&3+'8J,[-][3+5[=UC>%G3+>$7J$
MSA[8EL<Q9D*5DVJAUXZ/1N5:R+CO,L<HV,9$TR6],JE;#J/_`'4`L)N">@"$
MXK8>^/>.SJAN:_3*8<SLFX^J<Y(A=H,O-+_-!4370UFX>&NPIE`_$=*YHUV0
M=?B`2Z#Q"H,1T?[:/?ZS/M)V&;<MO-M=JG='GN%Q194G!1V7+%<7.6TK[26N
MJXID9&#*PQ%<34&Z*LB9L82/7)?F(&^+F4`/6+]1'DE]F7L'GRY*6;,8[DLG
MOMJ-^R%@W"*QIVRWEV71;$XYM:9%PRC5QE()5\+5?K;H&^8D.J91^$)1>&\[
MC_IXFC61[+FRQC(((/F+JQ<B,W3)ZDFZ9N6CC+F1$UVCEJN4Z"[99,YBF3,4
M2F*80$.(T9$]Y\N^<\06GVY?U3>VV%VPMVUB61EW).&;A?V/;Q@90L#$[B1F
M+(R=93-@V`B#2W)-VBXDFS("`BU!PD5,H%22Z2+17LGZ((````!R#A[J@QFM
M`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`
MH!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`T$`$-!#4*`^$[]51VD
M[D?W"X[FF!;9<3,4M#1$!NQMB%9'7>Q(0C=*)M;-B+5FF*JT82)31BY\X%$S
M<C=J[,(I_4'(+QE149L[$7ZD&)@(:R=E_<.O+\O813:*M+".Z.<7$S)*/0*F
MQA;"S;(J',+4C1`I$(VY3B*7RRE2D!+H#H9'"]Y]U3%\RE&322C7;9_'/VS=
MZP?LG"+MD_9.T2.&KUFZ;G40<M'*"A3IJ$,)3D$!`1`0&H*'4'?!OSVT]O;#
M$KFS<K?S.U81`%VMKVPS,B_OO(UPIHBJA:]A6P"R;V=EG!A*!S!T-6A#?-<*
MI)`)P$I5=#\RS?1OLWD=^?>;CZQ[0LR5/'R5RN+.VR;;;==*OHJRV,PL4LC=
M5V2:22;9]<CR-;E=W#.KD3:L6:`II?+;):&%U[&_M/TD.UUL%LSMN;-,7[9K
M:<M9NXHE%>[,K7FW1,@%[Y8N=-!S=\^F4_\`FEC$%DTV$<0^ADXUF@4P=8&U
M%).KJ>!/ZR-!RML>VR_3-W+@Y-SZPB5J@LX4*'^TM]:'$J!#F*4!#F.G&I+1
MDD>_G;<Q!BFW=E>S2[H/%F.[?N]_M8P$ZDKDB+%MJ&N1X^<XLM=5ZY?RS**:
MR:[QTN<QUCJ*"HHH8QCB)A$1@J]KJ>%WZPU%5;M\X)(@W7<'_P#=5`G%-N@L
MX/TAC+)`"82)$.<"@(@&NFFHT"='4MG<#V,M-WWZ;G;#<EO6LA(YCVQ[2<`Y
MQL1RC%%5N%Q!6MBR"+D^T4%`2^M^DF;'7>.3-@U^:\8(")>HH#0ENIUIVJ;T
M7FZ[]+EO/QI=3Q_(96VG8+N3"$^1ZB[-*2EB$3CI3$<\)%DP5<)*6FH,6!B%
M$/F1!^8\Q"=&>>6%MPLA@+]*5F^THHDBC>&X_>I?."(5DW:O"RBD3/L\?W'>
M:S=`J0+"W4M*UW;50VG3_P!6!>8T)DZL]"N[AVZ?]H_TW.SB(8P2@WQL[+B3
M)]Y?2L3F?(+9I;NF.7R+D1(+@3M[OR"V.J8=?A9!KP*&@1E0R#)7;7-B7]*!
M<-A2-NJI996M:U-\-Y-`:B:5+=\M=MOW0NT53(F#HCNW\1.4X\Y!#J3%N<N@
M:B%">+;7L(7[C_<ZEIS]./L1QM;CR2<Y<W@6#;6'KW08H.E)EM8NW59"V<HG
M>(HI_5(+73<-M14?\0`#A&06+QU&A5.CJ2UM?_2=C+X`Q)=5\;\-RV%\@7M8
M=KWK?N-<<,HV-MBT+MN6&92DG`MNF88.7;J%%<C1==8GS%%4!'@7I`)J7X_`
M\[K`Q)<?Z>'OS8.M>1OJ[<@[?<MPEMVW.90N.(^@=W5B[-;@+8N.4N9&*.O&
MC(XWRQ%)/EC`<1,@T(J;I%4VL%92J?I`%,!@ZBB`E'00$!`0,`@`@)1#4!`0
M&A4_/Z_4TY!8X>[SNP;,TW$S\M;>),<X0R/<#2W6)GDJ]B+(W$73<TFRB@.9
M)H:4<L8XY$"JJID%0Q>HQ2CK4EU))4(M[Q'=ZBN]OCG$>S/99LLS]<]WI9>A
MK\;7)==G,7MX@\:PTW;K>VK7AK3<W(G#1,R:X/F2L@_?-FQ$&I`,7I`5"`I)
M$M?J0<(Y`V^=I7M`X(R([<7#D+$C1U9%Z.V9W$R0EP6_@V*9R;)!XD54SMI%
M.DS-$5?PJ)HE$O`0J".+?XG?'OM[#LQ;E^V#L$W*[>;=E[JRSLRQIC*\I&V;
M=9.9"Z7^.;@QI8;F<F8*);E,\E9&Q[@M:.D3M$2&7.R!R8H")`*(J95CW]75
ML;3VQQERY/L_+K+=;#V:BPN+"<3:/S8*X<EL(\K5=2&R"J[1@XJT9F82^<)W
MI4G[)!0R8ME5$P^8!T9[6MG9[VK;->[1WR-R]NRUDY+W(XVR`ZPE"2D:[C)R
M4<WU<<K.-[P:Q#Q$DHS@;AR?<<,TA@.F51PQC3K@'RE$CF%DZ+TDD;%^W.\N
M_P#2V;E&$E`F<Y3W*PV3=V44JY:'+-.9'%4LSDL<%Z%B_4"YDXG%YSH@8.HQ
M94W@?C-2>/;7L+Y^GL[<Z-R=FO>[?MVV\L%W;^[)RO8=H`_9"B^3QU8]FW/:
M5EN&X.$R+$1D\COY-V!?PG!!`P#RT@J]KJ>9-NYDE,C_`*43)^(9@D@I<^VS
M>;9>.E8Q9H\!VSMZX,AP^1(,I6QD@6*BD[NA\B&A>D/D"'#0=!!WH[8?ZE'9
M[LFV%;;-J^2\)[HK@OO#5F25MW',V?9=J/+9?O'5W7'/)+0[J4O.)D%FP-)=
M,H_-;)"!RF``$``1`[\=]'<[9^]K]/,.Z#&=NWC`6;F2],'W-;MO7A&-VMWQ
M[%IF,D*HC,QT2\EFK=R*\0H<`375+\LQ1$0$=`E%HNCJ>9';>_4AX*V+]N+!
M&U)IMAW%9?SWBJV[HA4V<-&0D/8$]-3U\77<L:*-P`_EKE)'IH3J":P)PZJX
MJ@<I"CP&H$G5U,T[4.PW?=W&NZ,AW?-^V-IO#UB6M=*>1L?VS=L-*6H_NRY8
M&&4@<46C8-I7`0MQL\:XT9?*='DGR28R#EJ3Y?S#K+G()4J*A]WP:Z!KQ'0-
M1]/C0H:T`H!0'#\X.'+CZ0_L-'&[V+Z3%\:U^%'Z?N-`6`=``!X\]0$-/+@/
M&KN'#M>XE34ML?=[=]?J.8!U]WIK'[5>SA,FQJJW&M2!0"@%`*`4`H!0"@%`
M*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H
M!0"@%`*`4`H!0"@*&3C(^9CGT1+,6<G%2C-U'2<9(M4'T=)1[YNHU>L)!DZ(
MJV>L7C94R:J2A3$4(82F`0&@/@#[V?Z9Z[,9R5Y[J>W1:3N[\6NU']R9&VO0
MR)WEU8\^:91Y+36'FFIG%UV6F8QE#P)>N1CBZ@T!P@`)(R7X^PZQ;,.[1NV[
M->TM6Q,JWR[RUD3*MKQLYMGV99)3>/#;:+*DA^LC,OY;NA95&[;,AKQ:FZ[>
MQR@8CATS-^8.#1J*B(+J$\!Y-,8_N.]\3=N4H&O;<AFRXS_]5*.^N(Q?AVT%
MWH@(JG(F2T,5X^BCJ\$DBD5<G#0I73DP`<*<&T_10[/'9-P?VL;!5GEG3#*N
MZF]HA%GDW-CB-%!&/9*BFX7L+&#)V4SFV[(;.B`*JHZ/I90A57(E*":",%7*
MI[>4*D69IO\`Q/B7&=W96S?+6Y;F,<=0[NZ+MN:Z6A7L3;\2R)TN)!1$&CYP
MHI_F`F0B"1UE3G`A"F,8`$#-+6G;=N:V+<N2T7\?*6I<,%#SELR<4)!BY&WY
M>/;R$*^C1(4A!8/(YPFHCH``*9@T"@*J7CX>09G_`#J/C9!HTZW71)M&[QN@
M9),_6OTN$EB)F(F)M3`&H!K0%KM"X;0O6SK>N:RY*$N"Q[G@X^5MF6@U6SRW
MIFW91JFM&/(I9N'TCJ+?,EB&1$@=!TS!IP&@,$OB]L,8A"$B[O-;ELCD%>?C
M82+1MT[A2Z7-H6A<%_3;!&.AHIXI(KQMI6W(/02,0QCE0,1(#J&*0P&:0\99
M4_;T.]CH"$6@))LTGHI%:`;M4!)*,T7*#XL:\8MU6;I9LJ7J!1)-8OX3@`@(
M`!D[IDS?-E&3UHV>,UB@19HZ02<-E2%$#`11!8ATCE`Q0$`$!#4*`ZDY7WO;
M3\/W?-8QR?DR,B9:W64&I?J2=J7A<EHXWCKI`A+=/EJ[+?MJ8LK&#&<05(H@
M,^]8$,V.58=$!!00.S1+8LYVU8F3MZVG+%)/YT:8D3%K-4TG9RN?FL1*W,B1
M-R<04ZD]`.(@;CSH#):`M$C`0,NHFK+0L1*+($$B*DC',WJB)#&ZQ*F=RBJ9
M,ACAKH&@"(:T!=>!2@!0```-"E#0`X!P``X!H`!0'26)WI;0,D992PTRFI"X
M<M$6CV![9E\$Y=1>QS>4DI6-BGLE*SV-6\7#V[(R<,\3;R#ARE'JG;J"140*
M(T!W&CH2#A_F'B8>*BA6`"K#',&;(5`*/`JIFR276!1Y:ZZ#0&-Y!FK`MJ!_
MU!DE>V(ZVF+^(8&EKL*Q"*9R=R3#"VX1J"[])1%%U,SDHU9(`&AE5UTTPU$P
M!0&;))D323333(BFF4I$TDRE(1,A``A"$(4`*4A2```````%`=>)':#M/E[S
M'(TKMDV^260!=&?GO=_AK';R[#2`G^;^8'N!Q;RDH=^!^(+F5%77CU4!--TO
M+7AK8FY>[U85E:4!$/IN>>3I6I8.+A81HI(OI&1,Z*9JW81C-J98YS!TID()
MN&E`8[.Y"QG8V,)#)MQW/:=K8F@;4-=<A=C]\QCK/C;.*Q*_++'>G^6Q)%*Q
MZA3IB`:*%.4"@(F`!`BG!&ZO;MG>4F;)Q#=8GN*TX.+N)]8L]9%YXQN9"T)Q
MPX;PUVQ=HW_;-IS$G9LH[0.FC)LVZS`RWP"H!Q`H@3Z6V+9(V<,B6]!%:.E2
M.'30L3'@V<+IB84EW#<&X)+*D$1Z3&`1#CH-`4O^B;,#_P#J-L>0?^`17_TG
ME0%S/!PBD>2(4B(M2*2Z13BSQ[0\>GT'%0G0R,D+8G2H/4&A>!N/.@*1G:UK
MQZY'<?;D`Q<I:]#EG$1S9=/3@/0LBW(H333P&@+]J`B/(1#37EJ&O+7Q#6@-
M:`4`H!0'P#VSO2W=6I\L(#<IF9D1'I^6DM?4S)H@`<@,A++OT3EX<A*(>BOP
MWC\W\T8KK9S\GR<VU])_0KJ_0CHSKG_W#EG2*MU;A85MMO>_8IO\*>%#L-;W
M=?W[6]\DI<YJSB:.G^7<UG69+@IIX+*_D;=T<!\?\P!]-=S%ZF\XXJX7E?$@
M]_''B^MGSK6/D\^7S58U>B2Q9+<\?)OVVO%5G->M->!/=N=\C>5$"D$U$8;N
MM(F@*`^L^8B%50\1!6%N9LFF8=/!(0#R&NYC=9>:K3I..-=CW*'"_6I'SO5?
MD*Z-YR_L.5J^!&OO*_;NORI=MTIXUJ3[;W?YR8E\L+IVZ61(EX`JI;U[3D08
M?,Q$9.*F`+ZA/[:[MGKKEPI'*T^K[6FU]K/GNJ?W>6@37_<G,UVTZ[\FW:FG
MW4^$XNO?79W$\V_W],7K]);HV^Y$C##IU*0=SVO-IEU#CTD>D@SFT'WUW,?K
MGHTFEEXMVWY.OV(^?ZI_=Z<X8T6]*YFT;)N/="Y"]:;],%=7KHR=H#O>[.I-
M-/\`.6F6K84/IU?7V,A(I)B(_P`2L)./S&*'F!*ZV/ULY)NW?A797K<EOK&J
M^@^>:M\BO7338.]8_9&59[.#(<6_XMR,7Z]_83M;_=;V(7`F0Q<ZL(14^@?)
MN.UKQB#D,.FH**+01FQ-!X<5-/37<Q>J')67+AAEJ'C)47TG@M3^4_K[I5OX
MMW09WH=GPK^-.OBDKO%M[-E?"I.5O[U-IMV%(-O[CL./#G`.A):^X&.6,(\`
M+\J3=-%0,(^`E`0KMXO-_+&9<4+.?8;;V)NGUT/`:KT6ZO:)%SU3EO6++CV2
MQ;M/3)1=/.C)JA<CV)<A2&M^][.FRG`!*>&NB#E2&UY:"Q?+<1KMK/T]OBCD
M6''PG'[SQ.3H',6"JY^!E6*;^.U=BEZ96XF7`XZP`R1B*E'^(@]9?>01K9A<
MLW=MN<&O!IG'<IQ=.!M]NVE/SD<A%>OQ\=-.D0TY</BT'QJ[7#[VSTDQDI>[
MM7@TZ>#.>H+"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*
M`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@.E7<7W7H['MD>Y#=-]`A*RF),;R<M:
ML2Z_^5E;XEEVMMV.P>%#XSL%[MF6?U(%T-].!]-!XT!^:/V^^U7O0[V^0=Q^
M<QOUI%@P=7-=-]9TR<G)R3+(F=KC05F8FP(X6QBN5%WZJJ9Y!TGU-H&-,B`)
M*&,@@:3.VD=YOT[&Y/./;N[J<WL&S5"RMH1&>[IDL+Y0Q]+HD%Q:><;/CI5]
MCRZ62B?P.$I#Y:T:"Z9C-WL?)H+EZ@(F:A2>X_2F#70->>@:^OQJ#&:T!T`W
MR8ASGN&DMO6'<8+PEJX^)E1IF+,^1+LMIC?EJ-H_"_T-T8XQM+X]5NNTWUW(
MW[DU:.=K$(X(W1:0:OSC_&1)4#SHLC">]W;E&1%@.\2Y`SI!8BQ%O+VP8ON/
M&$_9%HL+OA,IRN+\C;<+UD+6NO)38EEV[:,<A*V<LX.Y?/84T2F8I%4'`*G`
MPW'^S7<@US?AQQ=F%LAW0:6LO$%F9DG<F7G%2=CPV/D=J,;B[)*-EY5LO+L#
M?+!$EV)K(.\?3-KW#%2<NHK+(OTA5*X1`I\1;#<TVA@UJLQV[7K#7SA3MTV3
MB+$6)W^:GUIVXMN<:7'FR)RS=$*XL7)@-$KDN&W)]LO%3)WC-3Z&2*BDNP5.
MJ*`&+6#M"W:MG]_QD#A3(MHV0G?5Z9`Q0TDS6'CME!?ZP[>F;,)/E+<LR!S'
MDE:PYF4S4_C".$S2SATJJ\1D5UNHZIDP+_(;<=YR6X3$M^!@?(S6>L/)^$8Z
M=ORWKAMV;1GL%M]M,=C.[`E+^N;.'YJFV#($FX&5LN'M1FP2.T/*G=/5U"J'
M`[T;#=H]\[;KYPE)J6K<UNQ\SL+LFV-PKZ8OV1NQ2X]SD#<=G+K/;H_-+EFU
M9B[F<6ZFDBRB)3)"T'Y`+"D1`A0+<G&;C]NLOO9QG;FTN8W%N=RV:+XR[AV_
M?S/':N%YQ'*]E6C:Z]E;DD[HNJ&NBVX'&CZ"4:.BMXZ53E;9312:`+CJ1`#I
MKD?;AO+>[IUL@0F!+LBI&.R[?\',WICJ6@DK0N3!UR;7+PQC9PQEV79F]Q<R
M%H!D5[&.0LF/MF*C[9^F^J$[IP0%U@,LE=B6:\<6C9D+CC&.0I>P)7;WLI<[
MJ\=1&6W1;ISS>&-\G23[<!:BDW<-\H#)9#G;)>)B^<'?L6UPL6XQIWHE43*4
M#!L];0MQ5Y15C&QO@;-.-L`)6UN`BL?[?6-UV?E>_L7Y0NV\8*2QWE%TTNG.
M%BV]B`LK!LW7Y,$3,7$E8!Q$I$"@[5*0#TVV([7;OQ1=6X3*V;"79.YEOC)1
M8:'O2[;T<W*9_BZ/QGB%H)K?AV<DI:ULLKAR!`2D@]*T8L573\3JG("8I%`"
M']XFVS/.3L@;R7^/X.Z4HO+6VW9]C:SKBM*\FMHS[V9L;<5D:YLF,(.8;3,;
M,6^_A+$N8CCZH#(=15Q*@<R@&*`'5>6V3[G;%W?/)7&T!D`MK6GE^R+EV^W7
M;;RU6]CVIMXMK'$4PD\+W%E"Z<KN+^MR(F+H;S#67AD[0E5)9Q+DDR/!6`5F
MH'6%#8IN4O>Q\KP-X;4,C'@;IPOMMNB8QR_FK3AHFX]P.&=SEN7KD]O&R#W<
M/?\`<%^7G(XNEI5K'7C<$E'JW*1,Q3@UZ42@!WBB^WO,7EF&U[XR-B6Z'D/<
MF^3<-<.0TYO)4R*+C:?/X=NI#%=GST-&WRHP<V`GD%M"*!;R9%4DY)`'"J(A
M\U0P'6!SLEWTG=X<8W`SR\NI;6,,.6?A>;MB0L>Z9;;_`'/8.7KV?7:^G;[N
M[,$&_LA>1LY:"<GEVL3=BDU$-QC%DQ,D#=4">[E[=609FPW1TL;SLCD7+K#N
M46SF]Y-Y*D'*%UVWE5QE.4VV05PE>W8K'?Z81G#6ZM#-&Z8)07\C<#.`,!VZ
MO[;C?UY=LK%&&L:8L_T?D#'$#MJO!E@:^IF&CV\Y+X&R)C[(UPXCN&>9S-TV
M\W1O=2RW3%%V9XZ8E5=HJ+&!(#]($?;B3;J]UMK7DK96TF[L56G!6OCAE<Z&
M0;BL.Q-R^:X8N:+%NS,^!,97=8^09YG9F/Y[%=N2+1R]>RK!.;EG;=%`R*)%
M75`0/:6R&_\`(F3;<3GL#7]CW9LOEK.5TV=MSO;(R95K#@)/;/:EF1[BZ;?M
M3(<TTC[?O[-K%_+15N(R#]M$N`!\8C51<"I@=;\I;4<M8`V\8Y>S&.LFN"W[
M@78)8.X>#C,U2S:[<K[DB[T\+M[FMV2N]S?2CDEZ35ER4E&FF2ND6BC%<&AW
M0(`F4@$F7[M;W"2T9,P5F;4\AP>UJ\,[7;<F.L&3MQ0%[7AB!(N"K;L]">7Q
M:[S];&.HZV,DY8/,2+1-Y.3#>SU4PDDHTJS_`%;@5V,ME&Z"8Q<\R3D?'>1P
MW*V+8_;5B,22=S923=W!;]S89D+7AMR<C&&C+X=6V5S*P[*0++.UP$]Q1QRD
M/\\#`D`';;81:%TS&X7,S=>[%+PP5LQN#)>W_;Q<<;>#RZ8F\%,O7/%9ENT)
MF0*^70E;AP-;+N&Q^4RXN%&RC)X7J*J94H`>Q=`*`4`H#\VQ/Q]GWU_GP?TW
M+>5E*=C*O<;=:<,>XQ*,5+B7O%6ER]A?LJSVJCW%GMW[?/;]9SE_$'M']E1&
M*BJ16PF+X5PQV)]VPJA'_+](\/;K_P!E8IO;P[*>2-&YLNMK?Z_K*I(1Y^@-
M/0%6X(M*J1$;UR/NLWF33/\`C(0_`0^(I3<!TUY@//2JRMPFJ254_,UE<DMW
M"GWT55Y.E4_%.I7-]6IP.U.HU.``8#ME%&YP-H'$#(F(8!K);<K2I;E)+PE+
M[S!?C"]!QOQC<B]ZG&,T_1-27T$B065<I6S\L;=R9D."^7H)`B+UN6/*40Y:
M%:R:9=/1II71M:KJ=FCM9%Z-.Z;^\\KF<E<G:@FL[2=-NJ6_BQK+_D$Z6]O<
MW?6R32&W(9:2`FG2F_NIU-):%X@!DYL)`IP]`^%=JSSUS;C0^';U'*4-].+]
MX\)J'0'HKJ+;R>6--=QKWK=A1]?"UM)MMONH;Z($"%_WE)-D)Q$MQ699TF)P
M`?PG4+#-5M!_JU]-=''ZI<[8S7!D_&C^/2OIV'A-0^4?H)GU<=&O6KS?O6\C
M*A'T0C-Q5/`FV![S6\!B)0F&N*KC(``(_46B_BU3^M6*G4"!KIX$KOXO6GFV
MUMR;6-+S7W4/#ZC\C?1S-K^JWM7Q*]D,FVTO+XD)2]$G7O)M@>^1EE+Y9;BP
M7CZ2*'2"AX:YKCB#GY:F(5ZC,$+J'F(\:ZUCKCK%O_2\&S<\(S<6_!-U2?BS
MQ&I_('RTZRT;F#-M6DMOZS:L2:]$+D6_);29H+OCVTJ`!<>WRYFHZA\Q6$ON
M)?E+KXD0?PD<8P>LX5V;77/#C#XF1IMZV_\`GHW/^2DG]QX'4?D(UQ3IHO,6
M)=?]=9G:C^="=Q^7L[28H'O3[:W_`$!.63E^`,;\1BPUNS"2?G\;*X2*F*'B
M/0%=BQUNY9N)*]9OVV]^RM#R.H?(OU;QH\6!DZ3E^$;\X/UW(13]#KWDO0_=
MEV82_05>]KK@!4'3_P`;L2XR=!O$#GC6DFGH'/@(UW,;JUR/>VO*<)=THT^T
M\5J'R?\`7;`@Y?LW'O1[K>5:E+T;42W"=PC9S-@F1IGZR45%!$`+,FEH(X#K
MR/\`G$8R*40`?$:Z]GJ-R/DRX8ZA9A/N;HSP^5\NW6_";4^6]2<5VJ,;B]$E
M-5]1+D+N9V^7$4@PF;L62)E``0(A?=N?,'4-=`25?$.`^C36NK9YJY9R'2SG
M8[_C(\AJ'3;J'IKX,[1-7M36Q_V2ZTFO%1:?H;)*C[SM:6`@QMT6_(E4TZ#1
MTU%O2F`W(2F;.U=0'T5U,?.PLO;B7K5Q>$JOT49YG(TC6=/]G/Q,BU+\:S=B
MO2Y)4])E*9@,4#`/4`\A`=0$/,!#@(#6R]YHM23I+8S?0"@%`*`4`H!0"@%`
M*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`Z0]R':.&^S9!N+
MVJI2[:WY?+%A+Q]J3KPISLHF]8*2C[ILQY(`D!E?RL+F@VI'8D`QP;'4Z0$V
M@4!TX[!^)O\`V[]MO%FWFZ['7QQG'#EUY,MG<794@U!M+L\M.+\GI)S.KJAJ
MG.P]U6NYC'D/*(&4:/XLR!D5#%*(%$U9TEO_`+=H[K?U$EH;TK0@SP>$MHN,
M[!=Y<R`1'Z:-R=NA@VMW-;0L&UW`$!.<D[(M.9B7%QNTNM)D5JW8J'^H,*:8
M5>[L/I^`-``/(-*$&M`*`TZ2\>`<>?IH!TART#377VT`T#R#SH#3H+_*'_#T
MT!KTE\@]>G&@```<@TUH!H`^`4`T#R#W>K]U`.D/+T^OU^?.@&@>0>7+P]%`
M:Z:<J`?V^Z@-.DO$=`XAH/#F'D-`.DH\1`.'H]WNH!H'D']N'WT`Z2\]`U]0
M<.&G#RX4`T#RH!TAIIH&GE0`"E#D`!X4`T#R_MQ_?0%,Z8LGR147S-J\1*NW
M<E2=MTG"17+19-RU<%36(<A5FSA(JB9@#J(<H&`0$`&@*G0/+PT]E`:=)?(.
M.NOIUX<?/A0%OC(>)A6_T<-%Q\2T^H=.OI(QFW8-A=/EU'3UR+=HFDB+AVY5
M,HJ?3J44,)C"(B(T!<J`4`H!0'DO=/9CV+7#\Q:/L>^+/44U`"VE?T\DFD<>
M1DT+A5GD>'](!Z*^:971_DK+K'X<X/;M4GL/UCH_SO=?]*]O)SL+._%NX5E/
MTNS\)M][3IVG7"Z>P=A1X592S<X94MH3B8R#><A[6NI-,1#@!S((6ZL<..@C
MU@(^->:R.A>AS36%EWH2\55?8SZGHO\`>'=0<.TX\P<OZ/GI]MMSL75^3<?Q
MN%]TJ>@ZTW/V"LK-S*C96X"Q)<I>H4$KIM"X8%0X!^$JB\6\GD2&'Q$"B%>;
MS.A&IVUQX6H1GM]UJA],T7^\0Y:N1KK_`"YG6)-;K-RS?V_E7G;_`$/2CKM<
MO99WP6_\TT1"XVO1)(!$!@;\;LEU@#40^6WN2/A0$3:<A.'.N!D='>;[2K;=
MJZE^,E^^?3=*^>3H5J,%+/NZMB7G_!OX?QHK\F5BY2/BZ25*;$==[F[<>^&T
M3'-*;;\@O$DM>I>VT8JZTA*'`3%_T[)R*HAQ\2AK7G,OI[SGAU^/@2NQ7X"D
M_J/IVD?,YT%U>,86.9\&Q<F]D+[O6EM_"?PH*/=1MT[SKQ<^&\OV6*B5W8HR
M5;)T>H3A.V+<\84O3^(14=1::8D`/$!T]-><OZ%K6.W\;!R;278[5RB]+B?1
MM/YXY'UAI:-K.D92EN^!EVKB?DG/CK7?5;]VPC[J*@84UA^2H70!(M_DG`0X
M<2*=)@XUI2C*TJ7$XOQV?6>FA_.+BMTDO!U^HJ0$#<A`?4(#]E8W.$7PR:4N
MYLURK#GZRAIZ>`5=&-RC)\$6G/N6_P!14!R#U!5J,Q<2XN&JXN[M*XGX3?V\
M*A[-CWE;S=J2A-\,I*J3V57>EVG,C]P_;56XK:Z(HU)*KK0N27+V%^P:G8U7
M>BG#%[:)E:GR]O[J@UG"'O<*XEVT16)?A/Z1+[>(U9))U252O%*E*NA6H\O8
M%&DS%<;DDI;45J7/_F"J\,7O2]1IW$DTUL97E'X!#Q$H@`>(\=?;4<$/P57R
M1C?M>]M\RN033,(B9,AAZ2\1(4?M"KIM;MAKSE)OA;K%=G879FLLU,!VJR[4
MX&#XVRRK<X<N1D3IF_;66-^_#W)SCY2:^IG-GC6;O]+:MS_*A%KTU3,^A\DY
M(@SE&'R)?D6)!$2?E]X7$T`@\-.DJ$B0H::>6E9H:CGV9<<,F_"2[5.;^BIY
M_4>4^4=15=0TS!R)/^#<QK<X>;CPK:NS:3##;L-S<$1,(S/>54"%`!!->\)-
M\EKI_$G(*.B&#UA7:Q^;^;+*2Q]0FHQ[ZU/'9O17I%G1X\KE_27)O<L?X-/3
M;DV_)^9*L+W!-W\0``EFF9?Z:!I,0ULRW5ZQ=PQSB/\`S5V%U*YYBTX9M5%;
M:Q7W'D<SY:.B67+CGHMBW+L^%?RH+TJ,]_<2I&=T#=JS`GU=Q67,`701_,+*
MCTC'T\#'C%H_GXZ`%=C&ZO\`.EIJ$W:GXN"/)9_RC]&<F;6/9U&Q<[K>9/@]
M'Q(3EY[=Y)T/W:L_MBD+)V1BZ6`H!U'(TN6-.<.'_P"E.N"`8?/33T5U;'6G
MFFW-K*Q;$X=C32;/(9WR8]/)U_4M1UBW.NYRMS2\%)J+E3O=*DJ17=[NLO22
M9PE;SK703FBKRD68](<^@CR&>!J/A\==/&ZV:A'_`$S"MORE^^>6RODHT;@E
M^HZ_D\5-GQ,2*C_&X;S=.^B;IN1),9W=+34`H2V$[E;"(_$:-NR(?%#U%=,(
M\1'7TA77L=;=-?\`I6'=C/OBZKZJGE<GY*]=BG^I:]I\^Y2LWHU]/82%%]U7
M!KT2_FEF9,B]0`1Z&,(_(0>&NID)TAC`']-=:WUGY:<5\6W?M_Q>+[#S&;\G
MG4FU7]4SM+OQ78KD[-/2X;?(D.,[E>U][H"LI><4)M-?K[/D#%`==.)F2S[E
MZ*Z-KJWR?D-*5R_%^-MI'F,KY6.KN+5V[&'?2_!R%+]-19G\=OPVL2?3_P"J
M;)D8P!\$I#W*PTUY=1CQ)DP]]=.WU%Y0G-6XY32[VMGTGG<CY>>L>.FYZ)=N
MP[[=RPU]-SB^@S:/W5[<902_0YFL(3GY$7G$V0\1Y:/2MC<_/2NG9YUY6O/A
M6=:HNUM+ZSS.9TBZFX,G"_HFIIK92$')+RX%)>IDE1^8<2RA2&C\GX^>]8`)
M2M[RMY4XZ_\`PRR'S`]U;\=>T.3I'-Q&W_76_P#".)>Y+YQQXN61I.IPBM[E
MBWTEYMP,L9W+;DCH$?<$(^ZOP_1RK!UU>KY"Y]:W(9V%-5A>M->$XO[3CW=-
MU&Q7X^/>A3\*$E]:+R4Y#_A.4W])@'[!&L\;MN?N2B_)IFFXRCL::9KJ'F%7
M(W[%O-=0\Z`TU`.8A[Z48W[AJ`<Q#WTHP:T>S>$Z[C34/,/?4)I[@]F\:AYA
M[ZDA-/=M-=0\Z$FFH>8>^HJB*H:AYA[PJ:,E[-XU#GJ&E`MNXTZBC_$7WA1[
M-^P-4VO<:@(#R$!]0ZT(33W,UH2*`4`H!0"@%`*`4!0#&,/KE),K-J215:IL
MEGQ$$R/%6:*AUD6JKDH%64;HJJ&,0AA$I#&,)=!,.H&Z/CF$4T281C)K'LD/
MF"BT9-TFK=,5E3KK&(BB4A"F674,<XZ:G.83#J(B-`5M`*`4`H!0"@%`*`4`
MH!0"@%`*`4`H!0"@%`*`:AYU%56G:!4@T$0#F(!ZQ"HJAN5>P:AYA[Z)I[B*
MJE>P:AYA[ZGP)HS3K)_,7_$'[Z>':1)J'O.GF`.4>1BCX<!`>/ESJ:-=C":D
MN*+K'O'47^8OO"E'W!M159.B-VH::^'/7PTJ'LWDEFEKCMZ`1%Q.ST-"MR_B
M7EI1C'(EX:\57BZ)`X>FM6>;A6]MR]:BEWSBOK9N8NGY^=-6\*Q>O7'N4(2F
MWY**;9$3G<]MQ:SL=;:V>L.$G9)5=)G%!DFT#O53H-7#M4ID4Y<QD1*@W.8.
MOIZM-`U'0*T7S%R^KBLO.Q/BMT2^-;KZ?:V?N1ZV/3#J7/$EJ$.7M<>!"*E*
MY^HY/`HMI)N3MI-5:W5[]BJU.U=@\,*`4`H!0%&LW^:90%"@HD<H%,F8"F*<
M.D`$HE,`@(>NIE&%R'!<C"2\54K24)?$@Z2[X\2EZU)>@CNY,.8LNY-0MTXQ
MQY<QEM2J&N"R[;F#F3$=>@QW\<L<W'QUKFW=%T/*=,G$QY+\B.U]]:5.]IO-
MG-^BOCT34\_$N=]K)O67Z[<]K])UUNGMW;++MZC2FVS&Y%EP,"B\.P<VRJGU
M`(=1#VX\B].G74``-/17#O\`(7)V9%QOX5N/BE1^NI]-TWYDNO>CT>!S/J<Y
M5_UBXKZ]5Z-ROH:KWG7RZ.S7LIG"G/%VQ?EI+G'4!MO(,N*29A_E;SY)M$Q"
M^0@%>=R.C_)>2WPPNV_*6SU4^T^D:;\['7_`@H96=BY\.V-^RHI^-;7PWL[-
MGF=?KB[$V'W8*&M3-N38!00-\E.:B+6N-N0>/2!S-D8)P8`X?Q:UYS)Z$:"V
MYXF5>@WV/:?2=+^?WGVQ:4-6T;2[\NUVKE[';\W"O%Y2XDGM2($N/L39+;?-
M&T<^65+%X_*1N.T9J$./@'6XC)&;(`B'DG7#R>AF7!-X.="G=*+K]WTGT32O
M[P'EQP5K5>7-0L2E[WP,NW=MM]K<+ENVV_XSV$"W#V8]Y$$)S0Y<77@0FO2$
M1>BL8JH``.G^7<,/%D`1\NNO/W^C?-]A5L7+-ZCW5BOK9]`T[YW^BN2XO)MZ
MIA7GOE+$M7(+T0N2?IIM[B"KB[<.]FT^OZ_`5S21$^`K6U)6Y<I#@&OQ$)$S
M#A80_P"74?*O.9/3OG3&;=W!N-)[XN#3\J2>P^AZ=\TG0C5'%6N8+$+LDMEV
MQ?L[7W\5I07DI-+L9!\]M[SU:0G+<V%<JPGRS#UF?6'<I4R@',PK)QRJ/1Z>
MK2N#?Y>US&?\_B9$?XC^X][I?4[IQK;5O2]>TF]<GLBEE64VWN23DFV1JNR>
MQRADI%D\CU2G*4R3]HX9*`(:Z@)'*21@$*YERUD69<-VU>CYVYI>MJAZJWF8
M=Y?S-ZS-?BW(2_1;#8Y3@.AB#S`-#`/`-..NN@<!K&WW[//89YQFHJ<HRC![
MFTTGY-T3?D7!'CH(<A,''P\*K*<([&U]9IW6JJNQ>.Q>LN!0`0*/B'4`>T>-
M6C[7N[3$O:EPQVKO7N_G>[L[=NPN+;F(:\>D*F2<=Z-2;BIM.4:I]Z+@D'_W
M@^ZJMI;RDVDFDT]G9[7TJI6D_$'M#]@U)JR7LU+D`@)"Z>`!K[J(U9[BM2$!
M`!#B.H:AZ:V;.YFO,N1?PA_;U_MK,5*Y+\/L+]E5[3`][+FC^,/Z`#W%`!H5
ME[K\BY)?P^W[ZO#WC4EN+FCX!XB``%9F:>1[J\RY)"`FU#D&H#ZQH:;3>XN2
M0AJ4!\2B(>WE^S6I*;BO1Z0.`CIH`<>&OE6:*7"C6FWQ/:R[(D3#0`(3@;@/
M04>?LJ7"+5'L3[5O]'B8KTK=_P!J::DNW8Z>-'L?DR[MU5$ND4U%$AZM=4E#
MI^/_`,,Q1"LD;M^Q#@Q[M]/\HYT[.'+VIQE=N>-NU'Z:-KU&6,;GN1@("RN.
MX&8DXE%K-RC<0T\`^4[)H%;T-2U2,4H963&7Y;^\X^9H&AYBKE8.-?J]UV%N
M27CL@MOIW&?167LJQP:,LF7ZU*!BZ`G=L[T_X3/C%'3TA6]#7=:MM?#S,E]_
MMO[SS]_I[R+?3>3H^FN;W4Q[4O/;);/09]&;DL],M"-LMWKTEX@5>6,[`?ZO
MK"+=0>NNI9YPYDL2_F\NZX]\G5GFLKH_TTR6YST3!<WW*5K_`)%KV?3O?:9W
M'[NMP[4I1_W)?.>G0/\`K8F!=<>',3Q>IO6.HUUH=0>;XQ489,'!;FUM])Y_
M+Z$]+<C8M)L6KCW\-Z]2OAW&;L-[.X)$I?FW+"/M-`,5W;$6;J]`_3D;?L$*
MZ,>I/-::;G9I^3^\>?R/EXZ8W7_,V,VW1]EW9Z'MHO&C\C,V>^G-"7299I9+
MK3F)H1X@8>&@@'R94I>/JK>M]4.8E+^=5F5OM7#^YG&R_EJY&N)RQ[N;:?C>
MX_H=M5]9E+;?WD9,O_5V?9CL?`2&F&HB/IT=N"A[JW8=5-3@ZW+-J4>Y53.%
M+Y7^7')S6IY=N/XL82?TI*GTE^;=P2X2A_U>.894>&OT\\^1`//0%&*FH>VM
MJWU8O_XW%7K.;D?*WI\G_8]7OT[?BVTO*G`WZ:E[0[A:)2_];B];77XA:70F
M.H?W07B@'77S&MB/5C&_QV%<<O"4:?2:$_E6SG'^SZQ9X?&W.OUET3[B5F@`
M`[QU=2(^/T\I#N0`?6<&^M9X]6-*_A8=Y2\XFA>^5CF6$*X^K8<O!PFG]3+J
MCW"\2F`/J[5OIMRZA*UAW.@CY?+E$Q$0&ME=5=#[;-](YESY6^=G[F3I<GV>
MW=5?^CV%T3[@6!3B4'!+Z:@/,5;825$/:WE%ZS0ZJ\M.5)0O17?MHO4:=SY8
M>I<$XK]G78]RR)U?YT(KZ2\-M^VW$PA\RX+B:=0:?]3:DM\/'^+Y!%PT#T:U
MMPZF\I3=)W9P7>X3:^A,YL_EKZK69-V<''DOQ;]NO_*FC(6N^/;&M^/)!6XC
MI\+JW+H2$-.8B/Y.<ON&L\.H_)\_]:4:?U=S[(&G/Y?NKEITGI3:[&KV/_G2
M]H;S=L3C0"9>MT@B.FCAM-MN/I%>*3`*V[7/7*=V/%'-MT\5-?0XIG.R>BG5
M+%_IM'R*>$K4OT;C+PWW8;;G6GR<S6+QY?.ER-O?]01+3VUG7.7+#55FV:>G
M[C2_](>I[@KD="U.5M[FK$Y)^32:?H9?D-QF`W.@(YDQJ<1TT`;R@B#QY<#O
M2Z#6>/-7+<J*.=BU?]9&OJJ:<NF'4:";GH6K)+?_`&6]V?Q"\I9KPZN(`CE3
M':@CP`"7G;PCQY</S"MQ:SI,MBR;/Y\?O.7=Y*YPLIRNZ7J$8K>WCW5_)+PC
MDK'+C3Z>_P"RE]>7R;J@E-?\#\:R+5-,>[(L?GQ^\T)<OZ]'WL'+7_L;G^"7
M9*[+67#5"Y8!8!#4!1F8Y0!`>0AT.3<!K)^T,![K]G\^/WF">DZK:_I,;(CY
MVYKZT7!.7BE0U2DX]0/--XW.'O*H-66;AO=>M?GQ^\P2PLV/O6;J\X2^XYRO
M&A_P.43Z^)%"&#WE$0K(K]B2K&<&ORE]YKRC*#I-.,EV/9]9S@<H\0$!]52K
MMINBE&OFBM?,=0::\=/Z3:^[36LCV"J-`4*/#XO\!P^TM5XO!^IA--T[0*A0
MYZAZRF_=QJT?;W5^KZPY1C[S2-/FI_S?L']U6X9%/BVOPH^M#YJ?\W_V3?NI
MP2)^);_"CZT;/J$M1#J-P_N''["U;X4_W-#XMI_PX?G+[S4%TA$``3:CR^!0
M/VB72H=N:57]:)4[;V*4:_E+[SDZ@]/^$W[JK1EJI]J->H/3[A_=2C'J]9L,
MJF00`PB`CQ_`<?L*-2H2>U?6B'*$?>E%>;7WFSZA+73J'_`;]U6^%,I\6SNX
MX5\T<GS"#_$'[:KPR[A\6U^$O6:B8`#7XO\`"8?V`&M5>Q5,CV;6;?F%TUT.
M/J34$?<!1&J\:[GZF5XU2NWU`%2C_,7^HAR^[J*&M2G7]U"%<B]^SS37U@5D
M@YG`/7PJ'.$=\HKTHGCA6E57S1P'?L4_^\>-4]!T'K<)$$!UTT'J.&E8I96+
M%TE=MI^,E]YGA9O7/Z.,I>2;^HMJ]T6TUU^JN&#;:<_GRS!'3U_,<%TK$]1T
M];'?LU_+C]YM1TK5+BK#&R)+PMS?V&//<K8OCNH9#)%A,>@!$WUEX6\VZ0#F
M(_.D2::53]J:9_\`46/_`'D/O-JWRYS#=:C:P,V4GN2L76WY)1,2>[E-N\<`
MB_SOAUH`:Z_/R59Q--.>NLQX5K7>8-#LQXKV7CQBNUSBEZVSM8W3KJ!F-+%T
M35KC?=B7W_(,(DM[>T"(`PR&Y;"J/1KU`7(5MN#\.>A&S]8YM/0`UJ3YOY8@
MJO/QG^3-2_1K3TGH,;H?UARW3&Y9UN;\,2]]L3`)#N4;$XL1!UN:QN<0UU^B
M=R<F'#^]&QCLHC[:T[_/O*&,U&[G6JM5V*<OT8L[=CY;NNV1)1AROJT9/=QV
ME;KXKXDH[/$P&5[M&P.,`XESRSDS$_AA[.OU\)N'\)R6R1(?\05S+O5'D>S)
MK]<3GX6[O^`>HQOD_P#F'R[:N+EZ[;B_P\G$@_4[_$O2B*I3O4[%H\5`0NG(
M<OTZ](Q.-IT`/QX`4TB>/U'TCIK6K?ZN\E6HUM7;ER=.R$TJ^E([V)\D'S`9
MM%D8&'C0_K,RW7T_#<_HJ1O,=]S:2S`WY+9><)TY?P_^6K;BDC&#^^]NDQP*
M/]/LKCOK5RW3;CWGZ$>JQ_D`ZT7FG>S=%M*NW^T7).GDL>C\JJO>17,=_P"Q
M2@8X06WC),B8->D\E=EJ1!1X?#J#=&7.`&\>&H5SKW732K<J6-/ORCW\44>R
MP/[NKGS(BGG\R:7C]Z^#>NT]"X*^M4(BF_U`MPB8XVSMCBD>'P&G\F/'(Z\=
M-4X^UVX>O0U<K)ZYW;BI@Z=",^UW9[&O#@3=?.FP]AIG]W)"$ZZIS0I_A?"Q
MG#U.Y<N+Z%YD-7!W[=S#\3C`8BPM`%T,!!=A=\^H'B!C">:C$CF#^@`KD7.M
M_,48.%C$Q;3?;!REZ^*GU'NL#^[PZ96)QN:AK>MWFM\8_`A%^5+;?K9"4]WK
MM]TP)PC[EQK:R9M1(6"QS'K&+J/`"JSSZ8$!+YZ<?&N5?ZP<ZW[?!"Y8A+OX
M?N/;8'R)=!L6ZKN38U++@O\`*9T[<GYQMVN&G=MJ0A<G=$W[W0"GUFX^[8Q,
M_4(IVU%VK;8%`V@#TGB(%LX+IX:'X5PKO47G:_LN9LEM[*I>@]_@?*=\O6G)
M*QRS8NR7;?R+MROIJJ^;2\CKY<VZ[<_>95$[IW$9IFDE0$#H.LD74FV,`Z@(
M"U:R3=MH(?W:Y=[F#F7(EQWL[*?AQO;])[[3.C72;1DEI/+6C6XQIMN8>/*:
MI^!/ADU)=DMK3VD)R<S-3:IEYJ;FIE8X:&5EY>1DU#<OQ'>N5S#KIYUS[N3J
M%^7'/(O<7XTJH]WBZ+I&##X>GX.';2W)V[?#ZHVT_*C6TL?R$->GY".@CH(`
MF70>/,>'$>KCZZUU"?$Y5_G/PCHJVN!V^&-*>[_B_P`W]X_2YK]_G\PPH!0"
M@%`*`4`H!0"@%`*`X3(@(#RU$PFY>?/D'C45NIU4MGD5G"-Q4N+B7<W3Z@*7
M`2@``4=0$`,8.'L#6KN5=KVOR*NU#A<8I*+[*4KZF8[,69:T^04YVVK>G$C_
M`(TIF%C)-,W]0/6BXF]M:M_$Q,BVX7[-J:;W2BFOI3^HWL'4-3TR:N:;DW\=
MI;/ASE!_G1=?O(6N+9_M>NPQSSV`\4O5%!$3*DLV&8+:CS$%XUJS6`?48*XE
M_E'EG+363@X[KW*GU4H>[TKJ[U2T:2E@<PZM!);$\B<TO1-R7T$%W%VO=EMP
M&.<F)"0"A^:EMW3=<3T#YIH%EUFA=/\`]L:\_D=+>3;Z<8X[MI[^%_>?0=,^
M:OKQIGLK7;N1:_!OV[=U>MQ32(4G>S7MED#*&@[HRK;0FU%--*X(F703$>7P
M2<$HL<H>0J>VO.Y71'E>ZJ8UW(L^331[W3/G:ZLXS_[SQM)S;?=.U=@O5:NP
MCM_)]9#,UV383_,-:^?YIN.AODHSUD1[TO/4H*N(Z:CQ'0/$$PKC9'0C3XJN
M#FWE.FWCW5\*5/<Z9\]^L1;6L<O8TH]BL95R$?1&=N=%W+BE1=K(;G.S-F]@
M"JMOY6QE-)DU%-%^TN:$74``U^(4V4LW`P_U``5QLCH=K$-F!DXK7XSN)_H,
M]II?SR\HSBX:KH^?C1>Q_JZLW$T]]>*Y!^I-LAB9[6>[V'$QFEM69<29=>D8
M6]XPJJ@``\2(2Z46?4=.7/C7!RNC_.6,Z1MVKJ[X2?VI'M,'YP.BN;;IDY.=
MB76_=NXTZ^NWQI>ED436QO=O;I3&D,$7JLF0.*L0G&3A!`NNHE_*9%X<VNG#
M0NM<#*Z?\W8>V[A77'O2JOH/:8/S"]%-4@G9YBP[<W_!O*[9?H=R$4_0_$BB
M4PUE^V1.6X,5Y%AN@=3'D+*N)ND73GJJ:.^4.FG@(A7)N:'KF'LR,/(2?;P[
M#U^%S[R3JU'I>K:;?AWQR;7VS3^@PQ1NY9&.F]07:J%$`%)R@JW4*.H@/4FL
M0ABZ>.H<*T;D;]E_SMF[%>,6>GQ[V-E[,.[:O/\`JYQFOSHMQKX5V=I5H'(8
M/A.4WPA^$P#Z/`:QN[8BE*Y/@3[U+[BD^)7)6E&;NIT:475/U4+FGKJ0P<C"
M'NUXUDH^U4*3K;?P[[MVYRV).Y!MM[ELDRZI!^$/6'O_`.-6C1>TVO*J-:<6
MGP*CGW)IOU)U+BF/2)1'D&G*KQE*6^+2[]GWG/ORK[-))I]J:*](1#73Q/\`
MLUX?LJQKEP(8=2CKQ#@'JUTT]U6*/>71/\9?3IK6:/NHTY^\_,NR1P$`'CQ-
MK^W3S]%7J8G%M->!7IF$1#3EQ_9K]]2MYK2MN*JZ%S2/J74=1$/A'ESX#61&
M*6XNJ"@=7(=!$`Y!S'@`\ZO&21BE%RW%U24Z=!#4!$?(.6M9$T]J-6Y;EQ=A
M>$3\?'00UT]/#C66,TE0T+EB7&]J+HDKTZZ:Z:@/(*VE<5.TTW%HKTG)>`AK
MU\=`'3T^0^564TW0QRBW&A5`ZX<0'7S#3[ZL8XV]OM;A]5PX`(CZ=/NH3*VO
MX!2JN1U^(>.@?"&GG57)+86A%Q5&6Q503&'01XCKQ`/*L3=74RI,H5S<0+QX
M<3>GEI6%W%N-J-B54ZHLJZH#U:ZCTF'3EP^+3SK"W3:="%N7$MQ:G*@#ITZA
MIP'4`\0U]-8Y231M1BXNK+6L;AKQX#Q](^'CZ*QOB_@F5-K<D_,M:QAT$-1T
MTX^G4=!XU1TK[<(R?>V_L-FQ*['VDTMNZBIYE"J8HE-U!KIJ/(!#4?'3VUB<
M8-UX(^MFQMN3<KM.%]B<U]"FEZDBRK`F<PB)2B`:AQ*&OV>BL7M[N*%.[X4:
M^NM?3Z394Z42E*G=[7^&6U1,@B;0A?B\RAZ:JX1[.*OY3-E7:;;<6I]G%-R7
MIBXT9;5")Z"($(''A\(<O+E6-QE_!<J_E,SPE.Y[*5I3[7P)?HN+^FA1*&*0
M1,7J(`:%^`PEY</`0Y5:]*;C%<4U3\9_>9I6DDN'AXNVB<?KE*OT%.H]>)"4
M$GCU,?Q:IO'!/0'$J@<>%4A?R;:X;<Y4\92"P\*\N+)LQN3[VXO9W>U;D_I.
M#\_GDCJ`E/3J0%)J4$YF2)TB(<PZ7(:#6S'/SXQHLB]%=RDZ?6/V-H]Q<3PL
M1_E6;,GZ6[6TV&O2\D`#Y-XW:B8=-!2N:<3_``Z::]#X.6O#RJO[0U6O^E7Z
M?E-?;L,;Y;Y=E[VG:8T]_P#9+/UT7V'+_NEDY#@ADG(2.GQ!\J][G(`#QU$`
M+)@&NE7_`&EJ,?:MW\R,UN?ZS<V?0/\`@WDV7LRTC2J?[I:^VJ]:8'->96^G
MR<N9.2Z1^'HORZ"].H"(Z?\`B@\]:G]N:W#:\S-I_O$_N*RY$Y%GLGHVE3CW
M/$Q_\VSE+G_.Z(%*CFK*R8%'4`+D"Z0`!\P#\STJRYDUR/N9V9'SNN?Z5*?:
M8+G3CI[?WZ%I"I_LME?HPC]-3B-N0W#)F**><\LEX#U?^?KE'7RYR`\JR+FG
MF.'N:ADT]'WE8]*>FMQ?SFA:37PQH&PVY_<>D)B)YXRV70W'_P`]W"/'30=!
M,^$:A\V\UI^SJ%_A_=XEO_1_IA-5>@Z3_P!F@<1MUNYM$3$2W`9>(`AJ(!?4
M\/'33747@C65<Y<V+=J&1ZRSZ)=)9[9\N:.W_N\2G/NTW1!U?_Z%S``AH`"%
M]3OD`^#OQUJ?^,^;'_\`D<GU_OB/0[I#)\,N6M&H^_'37JJJ^M%$KNYW3%UT
MW$9AYARON=UY>EU4?\9<U_\`B&1Z_P!\V8=!^CE?_P!9T'_L?_6EO4W?;J0'
MAN*S('$>5^3G_P!54_\`&7-G_B&1ZS+_`.@W1O\`_F=!_P"R?]:4RF[[=2(A
MKN+S+R\+]G0\?0[TI_QES8MVH9'K,D.A71N"I_PSHO\`%QE%>IRE]9;5MV6Z
M`PF..X?,HF$=1'_<&X@U$>?`'V@<:P2YOYM<F_VA?]?[YT+717H]""BN6='V
M?[/$M"VZ?<P?YA1W!9D$QM>H?]Q+G#7J'4?PR(::^BJ/FCF=[7J.35^/[YO1
MZ.])TEP\NZ0EV?V6V6!QN9W(*E-\S/V93Z")"ZY)NT--0`1_#*AP&JOF7F1^
M]J&4UX2<7Z))U7F;,>E732/N<OZ-7_=,?_-%L7W!9Z4*4%LW9=4X")=<CW?H
M`FUU'_\`EPXB(UAGKFM7(\,LS.2_WB?W'1M=.>GUJ-(:#HT9=ZP['^;,<<YE
MS"[`Y7.6\HN!-H`_.R%=ZH"`#KH('F1`0K$M6UA?ZYEO\J[*?JK2ALVN1N2\
M>7%9T;24WOIBV(_5:VF,.\@9`=@/U-_7RXX&_P#F+ON);74>H=?F21M=1J):
MKJ[=7EW_`,Y_>=&'*?*=5*&E:="*WI8]C;X[;1CZUPW$N(BO<5P+B/,5IR55
MU\>/S'9M:P2RLJX^*[=NRF^UR?WG6Q]$T*S_`$6%APM]RQL?_-EF7<NES:K.
MW:V@:!\YTX5X\A_[Q4W.L+G<>USN?G,Z%JQB6I-1LP4.Q)*-/)))+R6Q=A;!
M22-^),AOZB%'[>=853<I7*_E/[S>C>E3X2E/X;V-52JO0BF%)N.O2@D`"/+Y
M9.8<_`?&LBA5T<FEX^VOS9-+[C*U[/!&*X?&3?T)1^LXA(F`B!2%#CIP*`<.
M7(*B=F#WR4O*"M_3%NODRZE<:X9J"BMU%7])R7JH<&H<.&NG$/0/WU,+<(JB
M<EZ:D/V=BXY5[>-PIY*,:/S9KU:!KX:"&@:>/_;4O?O;\R\=W\+TR<GZWM*0
M_+V_<-06-Q`$``!TUTXZ>="T/>1Q'_$/L^P*&R;:`IAY#ZA^R@."@'@8/,-/
MLH"EK?+&H<Z$K><?\?\`S??4%S]+2OWR?S`B@%`*`4`H!0"@%`*`4`H!0"@%
M`*`4`H!0&A@`P"4>0@(#[:!JJH<8)`&@`/PAX"`#^T0&IJUMVU\R%Q+8FZ>E
MOUMOZ@*0#IQTT'4.!1T_94\3*RAQ;Y-^=']:9H"(\1.<5->74`:`'B&@<!`:
MQR4I;/9X.ZE?M(C:C%\3<I2[V]WE1(L<G:5LS0"$Q;\'*E,&AB241'OB&#TD
M=-U2CPK6G@8%Y<-ZQ9DO&$3HXVIZIANN'DY%I_B7;D5ZHR2(GF]KNW:XNL9G
M"V-'9E!,8YR6?"LU#";7J$56+5LKJ.O\U<V_RQR[DJE[#L27Y*/6:;U/ZCZ2
MN#!UW4[=M;DK\Z+RJV1+,=O3:-,%4_\`29C%*'UT5@YNY(P4Q'^)--&7%$N@
M^`%T]%<#(Z:<FY$DY8O"OQ9-'M].^8[K)I:I8UF[<7]=;M7:^?%"K7A7TD62
MO:QVT/`.:.=9&A%1U$HL[J2>)$$>0%2E(QZ;I#RZZXV5T>Y/OW..W"Y;7<I-
M_6>OPOFWZLV(\&<],RH]O'BQC7TVY19%\MVD[$,4QH',%Y,1U$R2<K`PDJ4H
MCJ(`<[8T6H8`Y5Q;O1+2ZN6)F7K>S=P*7UR1ZW"^<SF*W%0U70].NK\*S*Y9
ME7Q;^+5>&S;M(OE>T]>C<3#"9AMIX77_`"RRMKRS`P\0T`ZC-_(%)K_2.E<J
M]T7U"C>-E0E3\**C7U-GJ-.^<K2+E?VGHF1!+_)7HRIY_$C`CB3[9&XAB8_Y
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MXB'$#`/NT\JF?PXT]I%912HG.VF]V]U_-3^DNJ9]0`O`!`-/'^W&J*]:?LVY
MP?FZ&I>D[<O;E&E.Q3?\DN*"P!H0W+^;77R"LRK3;2OAM1KMPD^)/8_"GU[2
MY$5`.&FH#H`CKR].FE9E<=:&I.QL;3*I-4-`Z?3XZ#[JS)T=35X2H!P8`T`!
M'3^Z(_M\:O\`$\".$U%R?EH/'S+T^[6GQ/`<)3**AH/5Z/'4>?EI56ZNIGMX
M_'&M2E,L4>&@:!YFX\O+2L,IM.AD_5Z=I;%UP.&@:\!'4=?+[:POO-Z-JE-I
M;EE``O@.OI](5C<Z[#8A[Q;%50U\.8?Q!Y50SI5+8L<!$.(<S>/JJ&Z%DJ%M
M5/H&FG@'CZ?55&ZFS:]WTEN<'U(8--.7CZ*J9UN+4H/24=`U$>&E:_:;*M[G
M4MYC]'AK[=/1Y#0S+>6]0W`P>7'GS]%0C:Q_?]!0'XCKYB-8KO8;;+:I^+V?
M>-8T7AN+4IRUU\=/8`<_4-#<A[B+:L/Q^C3_`(U-#,H;"B5$->?\/[Z&1;RW
M+_>'V5BN^[Z3(BC.(``CJ&H:<-?.M9F:WVE`<>DP#ST`1]XF'T^=0C8AN+<?
MB81\QJ3;M^XBW+'U/KT^.G/R]GC0WEN10G#42AKIS$?>(?=K4%X>\BW*CJ<W
MK#[*E&Y#>6]7G[3?;4F0ICAX^0?OJ&Z%XQXE4HS#R+_+KQ\]1ZOV:U!D2HJ%
MO5_%[3?;0V%N1;C?B#^WG4EH[SA5'\7JT]__`!J3,4PCH42^>G'U?OJ&Z%HQ
MXBF4#37^D?OJ#*E14*0>=#/'W2G'F/K'[:$E.H.@Z_W?WUAC[R,MOWUYE&'#
MWC^T=:V#>.`PZ".OF-`4]`#?A'^WC4%UN*8_+V_<-02;Q'0!'T#0M'WEYE/_
M`-M#9`CP$!X:AI_;W4!3&Y#ZA^R@."@-A^7M^X:`X*WRQJ'.A*WG'_'_`,WW
MU!<_2TK]\G\P(H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0
M&@@`\ZE.@V]AM$A1YA^T=/=K56J[6'M5&D_0:@0H!H`:!Y!4[-_:0DH[([%X
M4-@(D`1$-?BY\>`\=>6E3*4I*E6J=P:<MDW5=SI]QOZ`\S!ZA&JJJ[:BG=L.
M([=-0!!0!.4>`E,83%'UE'4!JMRW:NQX;L(2CXI,E.:=5)KRV?2J/Z3'I&R;
M/F"B66M:W9,!YA(0D6]UUUUXN6BH^-:MS3--NQX+F/9E'N<(_<;]C5M6Q6I8
MF7DVI+MC=FG]9'LKMQP/-B(R6);#7,;\1D[=CVAQ]/6S1;G`?4-:,N6N7YIJ
M6'CM/\1'IL+J1S_IZIAZQJ%M>%Z>VFZM6ZF`R>RK;3)Z_P#IJSCC#K\41+ST
M<(:_RE0DP(73T`%<G(Y!Y4R$U+$A&OX.P]3B]>>K6)3X>M9,J?A*$OKB1_)=
MO?`+H#BR+><2<VO0+2YCKD)K_<D&;T3`'I$1KC2Z5<L2G6'ZQ&'<KFQ>7LGH
MK/S,=3+45^LW,.]+ME.Q6<O%N,HIOT$?O>W'89@4",R!>3`QA'Y?UK2#D2!Y
M:E318G,'M"N=D=(])<D\7*N17C[7W'I,7YJ^:K<*9^FZ?=?XD[L'ZO:5?HJ8
M2][;DH43&B<KLU-/P%DK651$/ZCM)A;7V%KFW^D=[BKC9L7'N</M3.[A_-9:
M:IG:+-/OC>^^)A$CV\LO--31UWV-)%XE+\Q6:8*&'F`F*:-<D+KI_,-<V]TH
MUN%79O6KC[O=]-6>GP_FDY,NOAU'3L^POPH.-UU[G'91;]M>XP*2V-;BF8F^
M1#6Y+$+KH:.NIB43>I-\1DIQ](!7.GTRYKC%R4+32[.)5?D>CQ_F-Z7WI*-V
MYFV6]WQ+-/T6R/I3:CN,C>H5<5SSOIX=<<ZB)(!T\2@U?G/IIRX5RKW(O-UF
M+G^J<45V*2J>IP^M_2N^DEJ\;:?X5J2^Q$>2N%<S10",ABV_&H%'XA"V91<`
MT`>'4V06+^VN+?Y>UZVJSP[JN]JHW0]5C=1N0,V*_5=8TNCW2G?4&_.'\'RJ
M1W(6_<<9J$A;T\P$->H'T+)M=!\=17:I@&@US+^#G6O9^#>KV^PSTF/S#R_E
M</ZMGXDZT]VY%U_)V[:]GH,574*4>E0P$'D)3_`8!`1X"!M!`0\JTY6YPE\.
M4+L9OM<'0[MN-JXN.S<D_!Q3_1;EZD6]0Z8ZB4Y#?TF`W(-/X=>-8XR@Y.W6
M7&EVQH9^&2]].$?PI0G%-]U9)*OAX%N5,77GXCY^@?OJC;;IV&2W!2K7=WE"
MH?7GH`:!Y^=0;,()+86I53K`.7F.@#S#4`Y^BH+[BW*''4.7CY^CTU@>\W%N
M7D6]4Y?/P#P'S]5066\H%A#WZ:>SG4&U8]_T%`<^@B'#@'#GS\:QW>PW4D]Y
M;%SZE\-1#00X\JQ&Q:MQ<>TMJI@#0-?7SY^'[*&=*BHBV'-J(^@1T]]6,ZW%
M`J81'7AP+^^H)6\H53"(B`Z<P^RL5WW?29$4"G$P^GA[`X5K,S6^THCC\(B/
M(`T_9H'V5"-B&XH3B&HCX::^P`J3<A[B+6J/'7P`PF]W#[Z&ZMR*-7Q]7WT+
M1]Y>9;U.8^S[*(W8;RWG'4QM?`1T]_[JDR'`80'JTY<=/5I5698;O24!Q^(?
M9]@4H9XQ352A5_%[3?;4ERW&_$'J^\:%H[SA5_B]GW5)F*4?"H9DM]I2'/KK
MKST]/IJID*<>=29H^Z4QA`!'7S&C).!;_P#`'V5AC[R,MOWUYE)6P;Q2J^/]
M7[Z`X:`&_"/]O&H+K<4Q^7M^X:@DW#R'U#]E"T?>7F<%#9-A^7M^X:`IE.0!
MZ=?=0''0&P_+V_<-`<%;Y8U#G0E;SC_C_P";[Z@N?I:5^^3^8$4`H!0"@%`*
M`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`-*JX1;
MJUM!MZ2_RA[JMV4[`JK<:Z!Y![JBB6XFK'2`\P`?74*$4^);V*LTZ"A_"']O
M^-31-U(->DOD%1PQK7M%$:`0H<0*'NJ:)[TBJA!.J2J<:C=!4HD5125*8!`Q
M52%4*(#S`0.`@(#4.$'O2]2+VY2M?T<I1\F_O,>>639LB!@D+2ME\!OQ`\@8
MMUU?U?/:GZO;6O>P<+(_I[5N?G%/[#I8VMZUAT_5,S*M-;N"[<C]4D8!*[>,
M$S(B:1Q'CY8QAU,H6UXIJH//_P#,:MT#^S6N3D<J<N92I?P[$OXOW4/0X?47
MGW`EQ8NKZBFNQW[DUZIN2^@C>7V5;8Y7\>*81F8W5J:*?3,:("(_B`&<HB0!
M]E<ZYT_Y/G%J6#;BWVQXD_K9Z?'Z\]7<1TMZW?<.ZY&$UZ/8V>/>1U)=NW;1
M(=?RH:ZHD1Y#%W;(AT^/PE?B_)[P&N7>Z5<J752W&[!ONE^\>CQ?F>ZM8RX;
MF5B74NV6,G]5".I/M@8-<`<(R\\DQ1A'X>I]!R)2:AP#_/@R"8./\U<F_P!'
M-#N1X;5_)A)=J:9Z?#^;CG^Q%?K.'IM^7>[=R-?1&XE]!'$GVI+?4ZAA\SSJ
M`CK\LDG:<8[`/+J.WE6@FU\=`"N7?Z)X6^WG75Y_:>GP?G(UFT_[=H6/<7;P
MY#CYT33IX=Q',KVGKV`#&A\OVLY#30A92VI9B;GPZOHW\CQ]05S+W1?-4N&Q
MF6G'O:=3UF+\Y>A2:EF<OY=M=O!D1FUY1E!*7I:(UF>UGG]J4PQMU8REP#@0
MI9.>CE!'B(#H[@Q3#7TFKE7>C?,ZEPV;V.X]_>>GQ?G$Z<NDK^%JMB3[96K4
MH^5(SK7N>XC24[;6ZYF`BVM:UI@"@/&.O6'*8W+D5^+$>/OKBW^EG.UEM2M6
M;D>QQ?U[3U>#\V'1[)5+^7F6&_PL63IZFT1?+[$MVL8H8JF&)YV!`T$8N2MZ
M2(?01XE^EESF,&GHKEW.GG-UF#^+AW)3KOAN\CU^G?,5T4RH\,=;C%M_XZ%Z
MRUY*,&J>-:[^XC&9VN;D(<3_`)C@S)Z/0.HBE:4F\*(`'$0.Q1<E$H>>M<^Y
MR=S3C0X[F!D./D>GQ>L_2K+26+S#I*@]W%-N7I<J-^HB^4QCDN&`PRV-[_C0
M*(]0O+-N-N`"&NNIU(X"%T](Z5QLC2M;QI?SEK(5>S]6EL\.+^5Z3V&!SARE
MFQX\75]-NP>W_2,95\EQU5>RJJO,P%ZS>M!,#MD]:&*7X@=,G38Q1`1$0,"R
M1!*/KK1OPRL9\%ZQ>AXRW+S.SBZAIN9)1P9V;K?X.1&;]$5M;\"PF71ZAU4(
M/+AUDUY!_>K6E<JJ-G3A;E7;%^HI%E"CQ(8.`F$=!#CQ`/`1\ZI5,SPAMW%&
MH;X3!YAY!I4FS;A'AW=I0*#H0VOB`A[PT"I,R5-B+68PCP'QU#P]?W4-M;D4
MAQ^$1'CH%"\?>1;U1X"(<.(4-R&\H#?B'UC]M29"E$P%+H.OQ"(!IZO&JLRP
MW%(H.AA'U?8%#9C[I;U3AKX\S>7GZZDL40!UB`AZN/\`8?.A,=Y3*F#4P<=>
M'[-*DS%./A4,R6^TH#\_9]XU4R'$/#4:DS1]TI%!U`!#Q,`\?(>/V4+(X5!`
M0$>/X?WTX8]QOJW!.J6TIM0#B/\`;7@'[:L7*13E[?WT!QAR]]1VF*4FKB79
M3[30WX1]GVT-DHS"(F'C\(<-/3YU`.4>0^H?LH6C[R\S@H;)L/R]OW#0%,IX
M>W[J`XZ`V'Y>W[AH#@K?+`1T`1H2MYP\=.?'S]/G[Z@N?I;U^^3^8$4`H!0"
M@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`
M4`H!0"@%`*`4`H!0&F@>04%6.DOD'N"IJR:L:!Y![@J*LJTGM:51H'D'N"E$
M]XX5W(UJ*(DTT`>8!4@:!Y![J5%6-`\@H-[J]YK04--`TTT#0>8>`Z\Z/;L>
MX+9N+8[A(5\4Q7T1%O"F#XBNH]HY`?659$X#6O<QL6<7\6U"2\8I_8;EC4,_
M&?%CW[UN2[8SE'ZFC`9?"^(IS7\VQ;CR2ZAXB]LNW')C:\^H5(T3#[ZTY:+H
M]Y5N8MF47V<$5]AU<?G+F_#G\3$U/4+4UN<,FZGY>\]G>B-979YM?F>O\RP%
MBY43ZZG0M",9*:#Y'8)MS$]@A7+GR5RC<<G+!M<4M^Q_>>HP^LW5O!C3%YAU
M6$5_M,G]:9'4IV[-FDGU?.P9"-3'#B>)E+FC=.?$"M9M,I1U\@KF7>F/)60G
M&6'%5\6OJ9Z7"^9+K7@[8Z[DW:?Y56[K]<[;=/#<1M*]J/9W*&,="T+OARFX
ME)%WU/`!!\=`D'+_`,?`>%<VYT@Y(X>&-F<?*<F>IP_FYZVXM)//PKC[YX=F
M4GYM)5]"6PC:5[..UYWU?EUP9@A3")ND4[GA'Y"B81X]#RVU3"4/`.KE7)O]
M%>6IOV,C/4>Q1G&B\-L:T/38OSN]7<5<.3CZ1=?>[-Q5\:1O47DDEX$=2G9+
MQ,X$X1>;,DQ_5J!0>PEL292AX`;Y:$<8X>T!K0O]#-"]Z&7?C)>"?VGI\/YZ
M^>K5V,LW1])NQ3V\'Q+4O1+VZ/QH_(C>8['I"E/^0[BG!^`])9C'"1=-0X`)
MV%T<=!\0*%<Q]"ZR_F-3N<'=*"/5V/G[S-BRN6XI]KMY;<O5*Q%4?F1E)]D'
M+"0":)SGC]WP'I"2M:YV.H^D6BTEI[JT+O0G5H-_JN;BW*[_`(T9-+\GA^GT
M'I,3Y]>5;D5^T]!U*#7X%ZU*OYW#]!&LMV6-T;<3?E=Y8@F``OPC^;W-&&,(
M>AU;9P+J'I&N7=Z*<UX\7&U/!N5V^PW%>5)=IZK`^>WI1>7P\C3-<Q]NVD<>
MXO.O&FO*A&\IV?=Z[(#BUMW'4R0.0Q^0V21CZ>)"RC%@'L$0KF7>CO/"APQA
MCM_EQ^\]AB?.CT'O6XRR<G5K#V^Q+"XY+S<&TZ[]G9LWD8RW:SWT1O7_`.BQ
MI$"=7Q15Y64[ZOZ"C.I',(^H*UKW2GG;'@N''MSE15X95/1X?S==`\RBEJ[M
MQ>[XF'>@Z>.QI/OWKS(VDNWSO7B2G^IVVY)5`NNHQK2+EM0`.90BY1X81X>5
M<S(Z?\ZVO8>GYTK3WUE"4:>*CM:\MIZ6Q\R'0J\OYKF;3X+NFY;?0[,:_G+S
M(VE=I&Z:($XR.W3-+<I?Q'#'-S.2Z@'(!:1ZX#R\-:YMWE;F3$CPW=-R(P_"
M4)R^QGIL'K)TIU3V</F?0Y_BN[;M/\ZY-+9W=O81I*8AR[""8)C%&38L2B;J
M_,;!NQETZ#QZOJ(A/3VUIST768;9X>4EXVKB_DGJ<;GKD;*C3%UK2+DOQ<S'
ME]5PP)]"S;`P@_A)IB)>!OK8F1:=(\>!OJ&R>E:5W'R,>7#?MSA)K=*+3^E(
M[F/JNEY:XL3*QKJ_$NPE^C)EC5.0@"!S`0>'`X]'B'\VE44)M52?J9U+=)*D
M6F_!E)\]`VH`LD.@"/!0@\O^:M>3]II[ZF2.V7"MLEV%,<Q1$-!`>'@(#XC6
M;BCWHZ23<7)>ZNWL.,_X1]GVA4MI;R8QE/;%-KP*93E[?WU'%'O1#3C[RH<8
M>'KJR3E[NTK%ISJMJ-AS?PZ>7'7VU%&MZ9L3VNJW%,`:G]0B/KY_OJO%%;*H
MI5+:SD-R'U#5J$Q:XDNVIP5!L\4>]&Q30-`UUX`/JY\*50XH]Z*8_'3V_=5E
M&4ML4VB8M2]UU\CCJKV2X'LGW=OJ#:B^&6R7<;%-`T#77@!A]',-*E)R=(IM
MEE%R]U-G!6\#0W(?[>-15/<R5O.+RJKWK]W87/TMZ_?9_,"*`4`H!0"@%`*`
M4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0
M"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4`J'N!3+%`
M=!,.@:CH!C``>G\6H55R2C[2CP=O%N,5Q0;7Q*/;LWJGJ:J65\6$Z#!(GA0)
MI\7UX,#!IX]7U&@:>=:-UZ7Q?XBOE;^UG2QXZO\`ZJ\A?D<?WLB6>_\`;4!C
M_P"JO]BC'U'YHW`./P$>''J"0$1#TZUHW8\M.3>3^H_$[>)VT_3M[OH/1X,>
MH\8IZ>]9E'L^'^LI>CA7U$)3S;MO*BJ%R&V4`<QC_-_-WF$D3@81^/J%=9,Q
M3:^D!"N;=L\@2;^-^S.+MK.ROM/H^E3^9NW87[(7/3QZ;/A+4W"G93A5*>78
M0S,61V?I$3A*O=B29C#\7R[_`,318@8=>0LKH:B4WEII7'NZ;TG^'+CEI3A3
M;7(M)4\7Q[CU>+JOSGV&IXT>?7%?[/J<UZ5*S*+]*:(\D<%]DZ2`Q74]LV0*
M81^*/W"6U%B!A\2_09,;E*8/57(GHW1RZN&,M(A)]L,NUQ>BMRE.\]1C<\_/
M/AQ4K5CG65I?Y32<BY#TJ>$TWW-[NPP"6VD=DN2XH90P#&B/XORK=I"H:%\`
M`%\ANB]/EPK7GRST=O)1N96#!+<_UNRO_F'H,/JW\]&++B6F\R7O"6@3?Z.%
M!^MLP1_L2[+[\#"CN4L.'UXA^7[O,>G`.'#I"1FI`--?.N;D\E]&IR36HXRV
M?P<VRE^D>KPNOWSQ8\:2Y7U2\T]]SE[,K_T=N*^TCR5[=7:3<G/^5[X[:B2C
M^'7<M@N0`O+0!^K^(PAZZTI<@=(Y^U#6,:"[GEV7]/&=S'^9+YSK4U++Y%R[
MS_\`)-2A7^*H-?>8`_[9_;45$XQ?<CLEB8>KI!SES;W)`7R`W3.,#&`!Y\0$
M:UWT[Y";_F.88*SV)7L9JG91\56CTF'\T7S4V57(Z::A=F]]--U6*]"^"TO0
M8%)]L+9*;J&([HV"DC:?`64NW#CCSTZC,\F-?'R"N9+IOR7_`(OF+!X^RM^S
MO\N,]#C?-5\PU5^N=)N8%'\2QJ7%_%XL)QKYU1@3_MA;=`U&)[HVT93GH$E=
M5AH^H#"TRHN`>L*TKW3C0W%JWS'I=?&]:7\L]3@_-3U/HGG]*N=.+M4,7)^A
M_J"9@$IVSK`1ZAB.Y%L-D/Q:%?9=@(P3<?XOE3TD4NOEJ.E:DNG.F05;?,6D
MR?\`S]K[9'>M?--SA<:C/I;S_9?:XX5^Y5=U'C0IY[?(CV0[=16HG%COC[>\
MH/,`+N8MI@(Z%X%-]0@J`:US,SD+$MSC36-#N[-]S+MP:\DI[4>BP_F5OWU3
M4>G_`%#M3_\`*,J7Z"M_4_,P.0V)W4RZ@;;E-B\N`"/%CN\Q,CU!X=(2DHPX
M#Z>FL$>2IP7]EU+16^Z&78:]<KE?/Z#T.+\PFGS2A+E'GZU#\;E_49R]+BW7
MP(_D=H606`J=.3MITCTZZ#&[P=N2O7I_(5QD-J8-?3I6M<Y5S;;K;R]/G=>_
MAS,7?Y?%5#LXG6;0,Z;5W1.;\?QGH.L1;\U'$G1]ZXGYD?2>`[XBA,"\_A-R
M)-1,,7N1V]RI3:<?\OZ')BPG'3P`!&L,]$S%!MW,/<_]:QO\Z>CM=2.7[S48
MXVOIO\+0]9CZW+!5/28._L.X&`&!=S9Q]/%EDS&<B'`0Y#'W>YU]E<YZ;D6?
M;G+'<?Q;]F3]4;C?T'<Q>:-,RI)6K6HK\O3\^W_\3&B8T,0]!4$>J-ZQ'0!_
M/H`4M=!YN`E!;E#AS$X!5'9G5>[O_"C]YV?VAC_#^)PW^'_F+U?S?AU^@__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
